Survey results from Trier and Jena University show that in Saxony, Thuringia and Brandenburg democracy is in crisis. Most ...

Phase 2a study demonstrated rapid and substantial decrease in depressive symptoms SPN-820 was well-tolerated with few adverse events SPN-820 is a novel, first-in-class intracellular modulator of ...

Supernus Pharmaceuticals Inc. (SUPN) announced a promising data from its exploratory open-label Phase 2a clinical study of SPN-820 in ...

The lab will study AI for quantitative finance, including research in financial markets and its microstructure, quantitative ...

But amid the green energy boom, Ha’Kamwe’ is threatened by lithium exploration by the Australia-based company Arizona Lithium ...

The grant will support research into how climate change impacts human health — the single biggest health threat facing ...

Clarametyx is initiating the Phase 2a portion of a clinical trial on its novel antibody therapy CMTX-101 for cystic fibrosis-associated infections.

Doctoral School of Health Sciences, Faculty of Medicine, University of Debrecen, Debrecen, Hungary Department of Public Health and Preventive Medicine, Faculty of Medicine, Udayana University, Bali, ...

Phase 2a study demonstrated rapid and substantial decrease in depressive symptoms SPN-820 was well-tolerated with few adverse events SPN-820 is a novel, first-in-class intracellular modulator of mTORC ...

Imperial and the National University of Singapore (NUS) have announced a new partnership to strengthen research collaborations. The three-year partnership will see the two universities explore ...

Dr. Fillia Makedon, a Distinguished Professor at UT Arlington, who has received two National Science Foundation grants ...

MeiraGTx's clinical study of AAV-GAD for Parkinson's disease showed significant improvements in motor function and quality of ...